Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 13 04:00PM ET
3.35
Dollar change
+0.08
Percentage change
2.45
%
Index- P/E- EPS (ttm)-2.77 Insider Own20.85% Shs Outstand8.59M Perf Week8.41%
Market Cap29.38M Forward P/E- EPS next Y-0.94 Insider Trans-0.16% Shs Float6.94M Perf Month7.54%
Income-23.75M PEG- EPS next Q-0.32 Inst Own5.16% Short Float3.02% Perf Quarter-26.21%
Sales23.28M P/S1.26 EPS this Y33.20% Inst Trans-30.71% Short Ratio6.08 Perf Half Y-20.52%
Book/sh4.25 P/B0.79 EPS next Y45.38% ROA-40.67% Short Interest0.21M Perf Year-42.96%
Cash/sh1.73 P/C1.94 EPS next 5Y- ROE-49.65% 52W Range3.00 - 9.10 Perf YTD-38.46%
Dividend Est.- P/FCF- EPS past 5Y52.11% ROI-64.52% 52W High-63.19% Beta2.03
Dividend TTM- Quick Ratio2.25 Sales past 5Y28.83% Gross Margin24.74% 52W Low11.66% ATR (14)0.21
Dividend Ex-Date- Current Ratio2.97 EPS Y/Y TTM-22.23% Oper. Margin-104.63% RSI (14)47.07 Volatility4.96% 7.04%
Employees108 Debt/Eq0.04 Sales Y/Y TTM313.30% Profit Margin-102.03% Recom1.00 Target Price10.75
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q8.42% Payout- Rel Volume0.38 Prev Close3.27
Sales Surprise0.86% EPS Surprise9.09% Sales Q/Q401.65% EarningsAug 15 BMO Avg Volume34.46K Price3.35
SMA20-1.84% SMA50-8.84% SMA200-32.69% Trades Volume13,209 Change2.45%
Date Action Analyst Rating Change Price Target Change
Apr-03-17Downgrade Barclays Equal Weight → Underweight $2.50 → $1.50
Dec-16-16Initiated Oppenheimer Outperform
Jul-15-16Initiated Piper Jaffray Overweight $10
May-22-15Upgrade Canaccord Genuity Hold → Buy $11 → $17
May-08-15Reiterated Barclays Equal Weight $20 → $13
Oct-07-14Initiated Barclays Equal Weight $28
Sep-12-24 08:30AM
Sep-10-24 08:30AM
Sep-05-24 08:30AM
Sep-04-24 04:15PM
Aug-15-24 08:00AM
04:15PM Loading…
Aug-08-24 04:15PM
Jul-02-24 04:30PM
Jun-26-24 08:30AM
Jun-11-24 10:50AM
Jun-04-24 04:30PM
May-28-24 03:32AM
May-16-24 08:18AM
May-15-24 09:10AM
08:00AM
May-14-24 12:00PM
04:30PM Loading…
May-07-24 04:30PM
May-02-24 10:01AM
Apr-26-24 10:19AM
Apr-23-24 09:55AM
Apr-19-24 08:30AM
Apr-12-24 08:30AM
Apr-01-24 04:30PM
Mar-24-24 03:54PM
Mar-22-24 08:30AM
Mar-13-24 11:45AM
Mar-08-24 08:30AM
Mar-01-24 12:00PM
08:45AM
Feb-27-24 09:15AM
08:00AM
08:30AM Loading…
Feb-20-24 08:30AM
Jan-29-24 08:00AM
Jan-28-24 08:07PM
Jan-16-24 08:47AM
Jan-12-24 08:30AM
Jan-11-24 05:00PM
Jan-05-24 08:00AM
Jan-04-24 08:00AM
Nov-30-23 04:45PM
Nov-28-23 07:33PM
08:00AM
Nov-20-23 09:20AM
Nov-14-23 08:15AM
08:06AM
Nov-10-23 08:30AM
Nov-07-23 08:00AM
07:40AM
Nov-06-23 08:00AM
Nov-02-23 08:00AM
Oct-31-23 09:25AM
Oct-18-23 08:30AM
Sep-20-23 08:00AM
Sep-06-23 08:00AM
Sep-05-23 08:30AM
Aug-11-23 04:15PM
09:15AM
08:13AM
08:00AM
Aug-09-23 12:46PM
Aug-08-23 04:15PM
Aug-03-23 04:15PM
Jul-28-23 04:15PM
Jul-11-23 05:30PM
07:00AM
Jul-07-23 08:30AM
Jul-05-23 08:30AM
Jun-30-23 04:58PM
Jun-28-23 11:47AM
May-11-23 09:15AM
08:06AM
08:00AM
May-10-23 05:35PM
May-09-23 07:15AM
May-04-23 06:25PM
08:30AM
May-03-23 04:30PM
08:30AM
Mar-07-23 08:00AM
Feb-26-23 07:24AM
Feb-23-23 09:45AM
08:00AM
Feb-16-23 08:00AM
Jan-19-23 07:24AM
Jan-05-23 08:30AM
Dec-22-22 08:00AM
Nov-23-22 10:00AM
Nov-11-22 08:00AM
Nov-07-22 09:15AM
08:00AM
Oct-31-22 04:15PM
Sep-28-22 07:15AM
Sep-12-22 08:00AM
Sep-08-22 08:30AM
Aug-12-22 07:54AM
Aug-09-22 09:15AM
08:00AM
Aug-03-22 08:00AM
Aug-02-22 04:30PM
Jul-21-22 08:00AM
Jun-23-22 08:00AM
Lifeward Ltd. Is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Yokneam Ilit, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lynch JeannineVP of Market Access & StrategySep 03 '24Sale3.301,6255,35847,658Sep 04 07:37 PM
Jasinski Lawrence JChief Executive OfficerAug 02 '24Sale3.842,66510,234103,309Aug 06 09:07 AM
Lynch JeannineVP of Market Access & StrategyAug 02 '24Sale3.841,7836,84749,283Aug 06 09:07 AM
Jasinski Lawrence JOfficerAug 02 '24Proposed Sale4.422,66511,782Aug 05 06:20 AM
Lynch JeannineVP of Market Access & StrategyJul 01 '24Sale3.831,8347,01851,066Jul 02 05:02 PM
Jasinski Lawrence JChief Executive OfficerJun 18 '24Sale4.223,46614,617105,974Jun 21 08:47 AM
Lawless Michael AChief Financial OfficerMay 23 '24Buy4.972,0009,9404,150May 28 04:42 PM
Turk Joseph E JrDirectorMay 23 '24Buy5.017,91639,65912,516May 24 08:17 PM
Turk Joseph E JrDirectorMay 22 '24Buy5.01844214,600May 24 08:17 PM
Jasinski Lawrence JChief Executive OfficerMay 21 '24Sale4.911,6207,954109,440May 23 08:24 PM
Lind Global Fund II LP10% OwnerNov 17 '23Buy0.7342,91731,32910,005,745Nov 21 04:37 PM
Lind Global Fund II LP10% OwnerNov 20 '23Buy0.7312,0008,76010,017,745Nov 21 04:37 PM
Lind Global Fund II LP10% OwnerNov 14 '23Buy0.6872,81849,5169,962,828Nov 16 04:37 PM
Lind Global Fund II LP10% OwnerSep 26 '23Buy0.705,031,2003,521,8409,890,010Sep 28 04:30 PM
Lind Global Fund II LP10% OwnerSep 26 '23Sale0.705,031,2003,521,8400Sep 28 04:30 PM